From an overall tumor rejection perspective (vaccinations done by intramuscular and/or intradermal injection and electroporation), there were essentially no differences between the two constructs, but the C1C2 linkage generated more active CD4+ T cells, and an IgG1 vs. IgG2b shift in antibody output, at least at lower vaccine dosages. The gene discussed is CD4; the disease is neoplasm.